Jared Barsky

Array ( [id] => 12411963 [patent_doc_number] => 09970926 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-05-15 [patent_title] => Bacillus thuringiensis toxin receptors and uses thereof [patent_app_type] => utility [patent_app_number] => 14/548905 [patent_app_country] => US [patent_app_date] => 2014-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 8 [patent_no_of_words] => 10584 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14548905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16304203 [patent_doc_number] => 10772974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Compositions and methods for cardiac regeneration [patent_app_type] => utility [patent_app_number] => 15/037195 [patent_app_country] => US [patent_app_date] => 2014-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 40 [patent_no_of_words] => 25917 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248645 [patent_doc_number] => 20150133641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'TRANSGENIC NON-HUMAN VERTEBRATE FOR THE IN VIVO PRODUCTION OF DUAL SPECIFICITY IMMUNOGLOBULINS OR HYPERMUTATED HEAVY CHAIN ONLY IMMUNOGLOBULINS' [patent_app_type] => utility [patent_app_number] => 14/543359 [patent_app_country] => US [patent_app_date] => 2014-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 55867 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14543359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11074229 [patent_doc_number] => 20160271193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS' [patent_app_type] => utility [patent_app_number] => 15/035973 [patent_app_country] => US [patent_app_date] => 2014-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12185 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11083833 [patent_doc_number] => 20160280798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/034171 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 39045 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107871 [patent_doc_number] => 20160304840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'Method for Producing Induced Pluripotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 15/030185 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16979 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15751277 [patent_doc_number] => 10617721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => Methods for genetic modification of stem cells [patent_app_type] => utility [patent_app_number] => 15/031169 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 19341 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10204691 [patent_doc_number] => 20150089679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE' [patent_app_type] => utility [patent_app_number] => 14/516606 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17481 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10289171 [patent_doc_number] => 20150174169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/516189 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 30262 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9908943 [patent_doc_number] => 20150064144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes' [patent_app_type] => utility [patent_app_number] => 14/515000 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12009 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10174440 [patent_doc_number] => 09204624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Non-human animals with modifed immunoglobulin heavy chain sequences' [patent_app_type] => utility [patent_app_number] => 14/498523 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 107 [patent_no_of_words] => 66181 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226963 [patent_doc_number] => 20150111957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Endothelial Cell-Specific Polynucleotides and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/495614 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16789 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14495614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10162760 [patent_doc_number] => 09193977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Non-human animals having a humanized signal-regulatory protein gene' [patent_app_type] => utility [patent_app_number] => 14/493745 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17464 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11986770 [patent_doc_number] => 20170290926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'Adeno-Associated Viral Vectors for the Gene Therapy of Metabolic Diseases' [patent_app_type] => utility [patent_app_number] => 15/511599 [patent_app_country] => US [patent_app_date] => 2014-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17469 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9814887 [patent_doc_number] => 20150026832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'Novel Inflammation in Vivo Model' [patent_app_type] => utility [patent_app_number] => 14/476626 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3732 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15309471 [patent_doc_number] => 10519426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia [patent_app_type] => utility [patent_app_number] => 14/916102 [patent_app_country] => US [patent_app_date] => 2014-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 35 [patent_no_of_words] => 23304 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9903810 [patent_doc_number] => 20150059009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'METHODS FOR MAKING FULLY HUMAN BISPECIFIC ANTIBODIES USING A COMMON LIGHT CHAIN' [patent_app_type] => utility [patent_app_number] => 14/473970 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41411 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960779 [patent_doc_number] => 20140363810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY' [patent_app_type] => utility [patent_app_number] => 14/467442 [patent_app_country] => US [patent_app_date] => 2014-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4545 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14467442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15944889 [patent_doc_number] => 10660318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-26 [patent_title] => Non-mammalian RAS transgenic animal model [patent_app_type] => utility [patent_app_number] => 14/911101 [patent_app_country] => US [patent_app_date] => 2014-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10651 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10365147 [patent_doc_number] => 20150250152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND VK REGIONS AND ANTIBODIES PRODUCED THEREFROM' [patent_app_type] => utility [patent_app_number] => 14/462499 [patent_app_country] => US [patent_app_date] => 2014-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 20180 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462499 [rel_patent_id] =>[rel_patent_doc_number] =>)